1. Home
  2. MESO vs CBRL Comparison

MESO vs CBRL Comparison

Compare MESO & CBRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MESO
  • CBRL
  • Stock Information
  • Founded
  • MESO 2004
  • CBRL 1969
  • Country
  • MESO Australia
  • CBRL United States
  • Employees
  • MESO N/A
  • CBRL N/A
  • Industry
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • CBRL Restaurants
  • Sector
  • MESO Health Care
  • CBRL Consumer Discretionary
  • Exchange
  • MESO Nasdaq
  • CBRL Nasdaq
  • Market Cap
  • MESO 1.1B
  • CBRL 1.0B
  • IPO Year
  • MESO N/A
  • CBRL N/A
  • Fundamental
  • Price
  • MESO $10.18
  • CBRL $47.64
  • Analyst Decision
  • MESO Strong Buy
  • CBRL Hold
  • Analyst Count
  • MESO 4
  • CBRL 8
  • Target Price
  • MESO $11.50
  • CBRL $50.43
  • AVG Volume (30 Days)
  • MESO 215.6K
  • CBRL 610.1K
  • Earning Date
  • MESO 08-28-2024
  • CBRL 11-14-2024
  • Dividend Yield
  • MESO N/A
  • CBRL 2.10%
  • EPS Growth
  • MESO N/A
  • CBRL N/A
  • EPS
  • MESO N/A
  • CBRL 1.83
  • Revenue
  • MESO $5,902,000.00
  • CBRL $3,470,762,000.00
  • Revenue This Year
  • MESO $66.05
  • CBRL $0.84
  • Revenue Next Year
  • MESO $348.27
  • CBRL $1.71
  • P/E Ratio
  • MESO N/A
  • CBRL $26.03
  • Revenue Growth
  • MESO N/A
  • CBRL 0.81
  • 52 Week Low
  • MESO $1.61
  • CBRL $34.88
  • 52 Week High
  • MESO $12.18
  • CBRL $83.52
  • Technical
  • Relative Strength Index (RSI)
  • MESO 54.91
  • CBRL 51.85
  • Support Level
  • MESO $10.00
  • CBRL $44.82
  • Resistance Level
  • MESO $10.98
  • CBRL $52.96
  • Average True Range (ATR)
  • MESO 0.59
  • CBRL 2.86
  • MACD
  • MESO 0.06
  • CBRL -0.18
  • Stochastic Oscillator
  • MESO 47.92
  • CBRL 36.44

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

About CBRL Cracker Barrel Old Country Store Inc

Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. Its restaurants are open for breakfast, lunch, and dinner, with menus that offer home-style country food. Cracker Barrel's biggest input costs are beef, dairy, fruits and vegetables, pork, and poultry. The company purchases its food products from a few different vendors on a cost-plus basis. All restaurants are located in freestanding buildings and include gift shops, which contribute roughly one fourth of total company revenue. Apparel and accessories are the company's biggest revenue generators in the retail segment of the business.

Share on Social Networks: